论文部分内容阅读
雅培 /武田公司研制的治疗勃起障碍的舌下含片药物阿扑吗啡 (从Ｐｅｎｔｅｃｈ制药公司拿到许可证 )2 0 0 1年 1月已通过ＣＰＭＰ认证批准在欧盟上市。雅培 /武田公司在大部分欧盟国家将分别以Ｕｐｒｉｍａ和Ｌｘｅｎｓｅ的名称上市 ,而在英国将用Ｕｐｒｉｍａ的名称上市。武田
Sublingual tablet drug apomorphine developed by Abbott / Takeda for the treatment of erectile dysfunction (licensed from Pentech Pharmaceuticals) January 2001 Approved for CPMP certification in the European Union. Abbott / Takeda will be listed in most EU countries under the names Uprima and Lxense, respectively, and will be listed in the UK under the name Uprima. Takeda